Leap Therapeutics Inc

NASDAQ:LPTX   4:00:00 PM EDT
0.51
-0.01 (-1.74%)
Earnings Announcements

Leap Therapeutics Reports Q3 2022 Financial Results

Published: 11/14/2022 13:04 GMT
Leap Therapeutics Inc (LPTX) - Leap Therapeutics Reports Third Quarter 2022 Financial Results.
Qtrly Loss per Share $0.13.
Revenue is expected to be $1.5 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.